US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 37.010
  • -0.650-1.73%
Close Aug 9 16:00 ET
  • 37.010
  • 0.0000.00%
Post 20:01 ET
4.51BMarket Cap-13606P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
94.45%-8.34M
25.13%-132.98M
-15.76%-594.74M
30.46%-97.88M
-9.50%-169.09M
-40.30%-150.16M
-59.21%-177.62M
8.77%-513.75M
-25.11%-140.74M
8.43%-154.42M
Net income from continuing operations
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
Operating gains losses
----
----
-99.64%120K
---32K
--133K
--0
--19K
-83.41%32.89M
--0
----
Depreciation and amortization
-3.90%394K
-17.79%328K
14.59%1.7M
14.49%490K
13.45%405K
19.88%410K
10.83%399K
-0.34%1.49M
13.83%428K
30.29%357K
Other non cash items
-52.32%3.11M
-8.41%6.14M
-8.27%26.29M
31.63%6.58M
-23.37%6.49M
-8.60%6.52M
-16.85%6.71M
353.03%28.66M
274.46%5M
220.11%8.47M
Change In working capital
90.48%-6.12M
-188.86%-103.38M
-1,175.12%-200.17M
-862.59%-42.56M
-102.44%-57.5M
-439.46%-64.33M
-1,863.19%-35.79M
83.21%-15.7M
89.16%-4.42M
51.44%-28.4M
-Change in receivables
53.94%-36.58M
-158.28%-61.42M
-8,466.95%-198.72M
-10,284.38%-37.17M
-10,066.55%-58.36M
-6,578.55%-79.41M
-730.21%-23.78M
123.51%2.38M
104.88%365K
69.77%-574K
-Change in inventory
17.77%-14.51M
-10,461.81%-14.92M
12.61%-60.65M
-84.18%-47.82M
141.33%4.67M
-13.11%-17.65M
100.87%144K
-325.30%-69.4M
-77.33%-25.96M
-650.24%-11.3M
-Change in prepaid assets
436.34%14.17M
-3,954.21%-4.34M
83.71%-1.87M
197.06%5.81M
-15.02%-10.22M
-13.55%2.64M
-132.04%-107K
14.89%-11.48M
21.48%-5.99M
-651.33%-8.88M
-Change in payables and accrued expense
48.67%33.51M
-26.38%-37.06M
183.75%35.12M
-17.35%31.47M
194.80%10.43M
288.20%22.54M
-978.52%-29.33M
12,928.42%12.38M
-16.13%38.08M
82.95%-11.01M
-Change in other current assets
-114.07%-1.06M
-37.52%10.8M
-48.55%25.94M
147.19%5.15M
-219.97%-4.03M
-83.10%7.55M
29.69%17.28M
193.89%50.43M
80.66%-10.92M
-21.39%3.36M
-Change in other working capital
---1.66M
--3.56M
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
94.45%-8.34M
25.13%-132.98M
-15.76%-594.74M
30.46%-97.88M
-9.50%-169.09M
-40.30%-150.16M
-59.21%-177.62M
8.77%-513.75M
-25.11%-140.74M
8.43%-154.42M
Investing cash flow
Cash flow from continuing investing activities
75.81%-90K
-13.13%-293K
-101.13%-674K
-100.00%4K
-100.04%-47K
-100.45%-372K
99.90%-259K
-75.81%59.89M
46.07%124.13M
-30.54%124.78M
Net PPE purchase and sale
75.81%-90K
-13.13%-293K
55.77%-674K
100.47%4K
76.02%-47K
4.86%-372K
-201.16%-259K
-38.17%-1.52M
-4,378.95%-851K
44.32%-196K
Net investment purchase and sale
----
----
--0
--0
----
----
----
-75.31%61.42M
47.04%124.98M
-30.57%124.98M
Cash from discontinued investing activities
Investing cash flow
75.81%-90K
-13.13%-293K
-101.13%-674K
-100.00%4K
-100.04%-47K
-100.45%-372K
99.90%-259K
-75.81%59.89M
46.07%124.13M
-30.54%124.78M
Financing cash flow
Cash flow from continuing financing activities
2,623.53%42.49M
-72.33%108.21M
7.89%394.5M
75.46%-3.91M
-40.37%5.75M
132.95%1.56M
3.82%391.11M
-6.78%365.66M
-104.15%-15.95M
354.53%9.64M
Net common stock issuance
---98.76M
-74.31%98.76M
1.12%384.39M
--0
--0
--0
1.12%384.39M
-0.06%380.12M
--0
--0
Proceeds from stock option exercised by employees
-80.24%5.16M
-46.51%9.48M
198.01%76.65M
616.45%27.09M
-45.89%5.76M
257.32%26.09M
342.95%17.72M
45.64%25.72M
-1.33%3.78M
328.82%10.64M
Net other financing activities
-835.09%-229.36M
99.75%-28K
-65.60%-66.54M
-57.16%-31M
98.90%-11K
-103.79%-24.53M
-48.31%-11M
-594.23%-40.18M
-8,223.63%-19.73M
-177.84%-1M
Cash from discontinued financing activities
Financing cash flow
2,623.53%42.49M
-72.33%108.21M
7.89%394.5M
75.46%-3.91M
-40.37%5.75M
132.95%1.56M
3.82%391.11M
-6.78%365.66M
-104.15%-15.95M
354.53%9.64M
Net cash flow
Beginning cash position
-57.33%327.03M
-36.30%352.3M
-13.82%553.07M
-22.54%453.5M
1.91%617.34M
20.68%766.36M
-13.82%553.08M
13.18%641.76M
105.20%585.45M
122.43%605.76M
Current changes in cash
122.86%34.06M
-111.75%-25.06M
-127.81%-200.91M
-212.59%-101.78M
-717.05%-163.39M
-416.71%-148.97M
3,233.39%213.23M
-214.95%-88.19M
-109.14%-32.56M
-252.14%-20M
Effect of exchange rate changes
827.66%342K
-473.21%-209K
127.66%135K
212.30%584K
-47.74%-458K
89.04%-47K
-12.50%56K
75.79%-488K
2,237.50%187K
-80.23%-310K
End cash Position
-41.45%361.43M
-57.33%327.03M
-36.30%352.3M
-36.30%352.3M
-22.54%453.5M
1.91%617.34M
20.68%766.36M
-13.82%553.07M
-13.82%553.07M
105.20%585.45M
Free cash flow
94.40%-8.43M
25.07%-133.28M
-15.57%-595.51M
30.81%-97.97M
-9.39%-169.13M
-40.14%-150.53M
-59.32%-177.88M
8.68%-515.27M
-25.84%-141.6M
8.50%-154.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 94.45%-8.34M25.13%-132.98M-15.76%-594.74M30.46%-97.88M-9.50%-169.09M-40.30%-150.16M-59.21%-177.62M8.77%-513.75M-25.11%-140.74M8.43%-154.42M
Net income from continuing operations 69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M
Operating gains losses ---------99.64%120K---32K--133K--0--19K-83.41%32.89M--0----
Depreciation and amortization -3.90%394K-17.79%328K14.59%1.7M14.49%490K13.45%405K19.88%410K10.83%399K-0.34%1.49M13.83%428K30.29%357K
Other non cash items -52.32%3.11M-8.41%6.14M-8.27%26.29M31.63%6.58M-23.37%6.49M-8.60%6.52M-16.85%6.71M353.03%28.66M274.46%5M220.11%8.47M
Change In working capital 90.48%-6.12M-188.86%-103.38M-1,175.12%-200.17M-862.59%-42.56M-102.44%-57.5M-439.46%-64.33M-1,863.19%-35.79M83.21%-15.7M89.16%-4.42M51.44%-28.4M
-Change in receivables 53.94%-36.58M-158.28%-61.42M-8,466.95%-198.72M-10,284.38%-37.17M-10,066.55%-58.36M-6,578.55%-79.41M-730.21%-23.78M123.51%2.38M104.88%365K69.77%-574K
-Change in inventory 17.77%-14.51M-10,461.81%-14.92M12.61%-60.65M-84.18%-47.82M141.33%4.67M-13.11%-17.65M100.87%144K-325.30%-69.4M-77.33%-25.96M-650.24%-11.3M
-Change in prepaid assets 436.34%14.17M-3,954.21%-4.34M83.71%-1.87M197.06%5.81M-15.02%-10.22M-13.55%2.64M-132.04%-107K14.89%-11.48M21.48%-5.99M-651.33%-8.88M
-Change in payables and accrued expense 48.67%33.51M-26.38%-37.06M183.75%35.12M-17.35%31.47M194.80%10.43M288.20%22.54M-978.52%-29.33M12,928.42%12.38M-16.13%38.08M82.95%-11.01M
-Change in other current assets -114.07%-1.06M-37.52%10.8M-48.55%25.94M147.19%5.15M-219.97%-4.03M-83.10%7.55M29.69%17.28M193.89%50.43M80.66%-10.92M-21.39%3.36M
-Change in other working capital ---1.66M--3.56M--------------------------------
Cash from discontinued investing activities
Operating cash flow 94.45%-8.34M25.13%-132.98M-15.76%-594.74M30.46%-97.88M-9.50%-169.09M-40.30%-150.16M-59.21%-177.62M8.77%-513.75M-25.11%-140.74M8.43%-154.42M
Investing cash flow
Cash flow from continuing investing activities 75.81%-90K-13.13%-293K-101.13%-674K-100.00%4K-100.04%-47K-100.45%-372K99.90%-259K-75.81%59.89M46.07%124.13M-30.54%124.78M
Net PPE purchase and sale 75.81%-90K-13.13%-293K55.77%-674K100.47%4K76.02%-47K4.86%-372K-201.16%-259K-38.17%-1.52M-4,378.95%-851K44.32%-196K
Net investment purchase and sale ----------0--0-------------75.31%61.42M47.04%124.98M-30.57%124.98M
Cash from discontinued investing activities
Investing cash flow 75.81%-90K-13.13%-293K-101.13%-674K-100.00%4K-100.04%-47K-100.45%-372K99.90%-259K-75.81%59.89M46.07%124.13M-30.54%124.78M
Financing cash flow
Cash flow from continuing financing activities 2,623.53%42.49M-72.33%108.21M7.89%394.5M75.46%-3.91M-40.37%5.75M132.95%1.56M3.82%391.11M-6.78%365.66M-104.15%-15.95M354.53%9.64M
Net common stock issuance ---98.76M-74.31%98.76M1.12%384.39M--0--0--01.12%384.39M-0.06%380.12M--0--0
Proceeds from stock option exercised by employees -80.24%5.16M-46.51%9.48M198.01%76.65M616.45%27.09M-45.89%5.76M257.32%26.09M342.95%17.72M45.64%25.72M-1.33%3.78M328.82%10.64M
Net other financing activities -835.09%-229.36M99.75%-28K-65.60%-66.54M-57.16%-31M98.90%-11K-103.79%-24.53M-48.31%-11M-594.23%-40.18M-8,223.63%-19.73M-177.84%-1M
Cash from discontinued financing activities
Financing cash flow 2,623.53%42.49M-72.33%108.21M7.89%394.5M75.46%-3.91M-40.37%5.75M132.95%1.56M3.82%391.11M-6.78%365.66M-104.15%-15.95M354.53%9.64M
Net cash flow
Beginning cash position -57.33%327.03M-36.30%352.3M-13.82%553.07M-22.54%453.5M1.91%617.34M20.68%766.36M-13.82%553.08M13.18%641.76M105.20%585.45M122.43%605.76M
Current changes in cash 122.86%34.06M-111.75%-25.06M-127.81%-200.91M-212.59%-101.78M-717.05%-163.39M-416.71%-148.97M3,233.39%213.23M-214.95%-88.19M-109.14%-32.56M-252.14%-20M
Effect of exchange rate changes 827.66%342K-473.21%-209K127.66%135K212.30%584K-47.74%-458K89.04%-47K-12.50%56K75.79%-488K2,237.50%187K-80.23%-310K
End cash Position -41.45%361.43M-57.33%327.03M-36.30%352.3M-36.30%352.3M-22.54%453.5M1.91%617.34M20.68%766.36M-13.82%553.07M-13.82%553.07M105.20%585.45M
Free cash flow 94.40%-8.43M25.07%-133.28M-15.57%-595.51M30.81%-97.97M-9.39%-169.13M-40.14%-150.53M-59.32%-177.88M8.68%-515.27M-25.84%-141.6M8.50%-154.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday+0.23%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%